|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ATP2A2-COL2A1 (FusionGDB2 ID:7832) |
Fusion Gene Summary for ATP2A2-COL2A1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ATP2A2-COL2A1 | Fusion gene ID: 7832 | Hgene | Tgene | Gene symbol | ATP2A2 | COL2A1 | Gene ID | 488 | 1280 |
Gene name | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | collagen type II alpha 1 chain | |
Synonyms | ATP2B|DAR|DD|SERCA2 | ANFH|AOM|COL11A3|SEDC|STL1 | |
Cytomap | 12q24.11 | 12q13.11 | |
Type of gene | protein-coding | protein-coding | |
Description | sarcoplasmic/endoplasmic reticulum calcium ATPase 2ATPase Ca++ transporting cardiac muscle slow twitch 2ATPase, Ca++ dependent, slow-twitch, cardiac muscle-2SR Ca(2+)-ATPase 2calcium pump 2calcium-transporting ATPase sarcoplasmic reticulum type, slow | collagen alpha-1(II) chainalpha-1 type II collagenarthroophthalmopathy, progressive (Stickler syndrome)cartilage collagenchondrocalcincollagen II, alpha-1 polypeptidecollagen, type II, alpha 1 | |
Modification date | 20200313 | 20200328 | |
UniProtAcc | P16615 | P02458 | |
Ensembl transtripts involved in fusion gene | ENST00000308664, ENST00000395494, ENST00000539276, ENST00000550248, ENST00000552636, | ENST00000337299, ENST00000493991, ENST00000380518, | |
Fusion gene scores | * DoF score | 17 X 22 X 11=4114 | 8 X 9 X 4=288 |
# samples | 27 | 10 | |
** MAII score | log2(27/4114*10)=-3.9295104814741 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/288*10)=-1.52606881166759 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ATP2A2 [Title/Abstract] AND COL2A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ATP2A2(110771948)-COL2A1(48378382), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ATP2A2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 16402920 |
Hgene | ATP2A2 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration | 16402920 |
Hgene | ATP2A2 | GO:0070588 | calcium ion transmembrane transport | 16402920 |
Hgene | ATP2A2 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum | 16402920 |
Fusion gene breakpoints across ATP2A2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across COL2A1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-3B-A9HL-01A | ATP2A2 | chr12 | 110771948 | - | COL2A1 | chr12 | 48378382 | - |
ChimerDB4 | SARC | TCGA-3B-A9HL-01A | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
Top |
Fusion Gene ORF analysis for ATP2A2-COL2A1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000308664 | ENST00000337299 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
5CDS-5UTR | ENST00000308664 | ENST00000493991 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
5CDS-5UTR | ENST00000395494 | ENST00000337299 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
5CDS-5UTR | ENST00000395494 | ENST00000493991 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
5CDS-5UTR | ENST00000539276 | ENST00000337299 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
5CDS-5UTR | ENST00000539276 | ENST00000493991 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
In-frame | ENST00000308664 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
In-frame | ENST00000395494 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
In-frame | ENST00000539276 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
intron-3CDS | ENST00000550248 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
intron-3CDS | ENST00000552636 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
intron-5UTR | ENST00000550248 | ENST00000337299 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
intron-5UTR | ENST00000550248 | ENST00000493991 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
intron-5UTR | ENST00000552636 | ENST00000337299 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
intron-5UTR | ENST00000552636 | ENST00000493991 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000308664 | ATP2A2 | chr12 | 110771948 | + | ENST00000380518 | COL2A1 | chr12 | 48378382 | - | 5166 | 2093 | 329 | 4723 | 1464 |
ENST00000395494 | ATP2A2 | chr12 | 110771948 | + | ENST00000380518 | COL2A1 | chr12 | 48378382 | - | 4974 | 1901 | 218 | 4531 | 1437 |
ENST00000539276 | ATP2A2 | chr12 | 110771948 | + | ENST00000380518 | COL2A1 | chr12 | 48378382 | - | 4601 | 1528 | 109 | 4158 | 1349 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000308664 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - | 0.00177949 | 0.9982205 |
ENST00000395494 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - | 0.001741597 | 0.9982584 |
ENST00000539276 | ENST00000380518 | ATP2A2 | chr12 | 110771948 | + | COL2A1 | chr12 | 48378382 | - | 0.001029352 | 0.9989706 |
Top |
Fusion Genomic Features for ATP2A2-COL2A1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ATP2A2-COL2A1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:110771948/chr12:48378382) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ATP2A2 | COL2A1 |
FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen (PubMed:16402920). Involved in autophagy in response to starvation. Upon interaction with VMP1 and activation, controls ER-isolation membrane contacts for autophagosome formation (PubMed:28890335). Also modulates ER contacts with lipid droplets, mitochondria and endosomes (PubMed:28890335). {ECO:0000269|PubMed:16402920, ECO:0000269|PubMed:28890335}.; FUNCTION: [Isoform 2]: Involved in the regulation of the contraction/relaxation cycle. Acts as a regulator of TNFSF11-mediated Ca(2+) signaling pathways via its interaction with TMEM64 which is critical for the TNFSF11-induced CREB1 activation and mitochondrial ROS generation necessary for proper osteoclast generation. Association between TMEM64 and SERCA2 in the ER leads to cytosolic Ca(2+) spiking for activation of NFATC1 and production of mitochondrial ROS, thereby triggering Ca(2+) signaling cascades that promote osteoclast differentiation and activation. {ECO:0000250|UniProtKB:O55143}. | FUNCTION: Type II collagen is specific for cartilaginous tissues. It is essential for the normal embryonic development of the skeleton, for linear growth and for the ability of cartilage to resist compressive forces. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 111_253 | 473 | 998.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 1_48 | 473 | 998.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 274_295 | 473 | 998.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 70_89 | 473 | 998.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 111_253 | 446 | 1016.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 1_48 | 446 | 1016.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 274_295 | 446 | 1016.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 70_89 | 446 | 1016.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 111_253 | 473 | 1043.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 1_48 | 473 | 1043.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 274_295 | 473 | 1043.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 70_89 | 473 | 1043.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 254_273 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D3 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 296_313 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D4 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 49_69 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D1 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 90_110 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D2 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 254_273 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D3 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 296_313 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D4 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 49_69 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D1 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 90_110 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D2 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 254_273 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D3 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 296_313 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D4 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 49_69 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D1 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 90_110 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D2 |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000337299 | 25 | 53 | 1253_1487 | 542 | 1419.0 | Domain | Fibrillar collagen NC1 | |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000380518 | 26 | 54 | 1253_1487 | 611 | 1488.0 | Domain | Fibrillar collagen NC1 | |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000337299 | 25 | 53 | 1215_1241 | 542 | 1419.0 | Region | Note=Nonhelical region (C-terminal) | |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000380518 | 26 | 54 | 1215_1241 | 611 | 1488.0 | Region | Note=Nonhelical region (C-terminal) |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 314_756 | 473 | 998.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 777_786 | 473 | 998.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 808_827 | 473 | 998.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 851_896 | 473 | 998.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 917_929 | 473 | 998.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 949_963 | 473 | 998.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 985_1042 | 473 | 998.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 314_756 | 446 | 1016.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 777_786 | 446 | 1016.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 808_827 | 446 | 1016.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 851_896 | 446 | 1016.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 917_929 | 446 | 1016.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 949_963 | 446 | 1016.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 985_1042 | 446 | 1016.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 314_756 | 473 | 1043.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 777_786 | 473 | 1043.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 808_827 | 473 | 1043.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 851_896 | 473 | 1043.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 917_929 | 473 | 1043.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 949_963 | 473 | 1043.0 | Topological domain | Lumenal |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 985_1042 | 473 | 1043.0 | Topological domain | Cytoplasmic |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 757_776 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D5 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 828_850 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D7 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 897_916 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D8 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 930_948 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D9 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 964_984 | 473 | 998.0 | Transmembrane | Helical%3B Name%3D10 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 757_776 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D5 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 828_850 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D7 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 897_916 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D8 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 930_948 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D9 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 964_984 | 446 | 1016.0 | Transmembrane | Helical%3B Name%3D10 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 757_776 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D5 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 828_850 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D7 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 897_916 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D8 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 930_948 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D9 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 964_984 | 473 | 1043.0 | Transmembrane | Helical%3B Name%3D10 |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000337299 | 25 | 53 | 32_90 | 542 | 1419.0 | Domain | VWFC | |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000380518 | 26 | 54 | 32_90 | 611 | 1488.0 | Domain | VWFC | |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000337299 | 25 | 53 | 201_1214 | 542 | 1419.0 | Region | Note=Triple-helical region | |
Tgene | COL2A1 | chr12:110771948 | chr12:48378382 | ENST00000380518 | 26 | 54 | 201_1214 | 611 | 1488.0 | Region | Note=Triple-helical region |
Top |
Fusion Gene Sequence for ATP2A2-COL2A1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>7832_7832_1_ATP2A2-COL2A1_ATP2A2_chr12_110771948_ENST00000308664_COL2A1_chr12_48378382_ENST00000380518_length(transcript)=5166nt_BP=2093nt GCGCGGGAGGAGGGAGCCGGGAGGAGGGGGCGGGGCCGCGCCGCCCGCGCCGCGCTGGGCGCTCTCGGCCAATGAGCGGCGTCCACATGC CGCGGCGGCGGCGAAAGGGGAGGCAGCGGCCGATAAATGCTATTAGAGCAGCCGCCGCGGAGCCGTCCCCGACGCCACCTCCTTTTCCTT CGCCGCAGTTTCCTCCGCCGCTGTCGGGCGTGCGGCGCTGAGGGACCCGGGCGAGCGCGCCGCGCACCGCCCCGCCGGCTCGCCTCCCTC GCCGCGTTCCGCCCTCAGTGGTCTGCCGGGCGCCCCCTCCTCCGGCCCGGGCGGGGCCTCTGATCGCCTCAAGAGAGCGGGGAGGGGGCT CGGGGGCCGCGGCCTGCCCTCCCGGCGGGCGGCTGAGGGCGAGGGAGGCCCTCCCTTCTGGCGAGGGGAGGGAGGGTGGGTCAGGAGCCC CCAACCCGCCCTGCGGAGCTCGGGGCCGCGCGAGGGGCGGTTGTCTGGGGGAGGGGGCGCGGGGTGATTCAGCGCCCGGCGAGGCGGAAG CGGCCGCAAGAGGAGGAGGGGAGAGCCCGTCCGCGCCTGGGCTCCCGGGGTGGCACGAGCCCGCGGCCGGAGTGCGAGGCGGAGGCGAGG AGGCCGCGGGGACGGGAGGCGAGGCCGGCCGGGCCCCCGAAGCCATGGAGAACGCGCACACCAAGACGGTGGAGGAGGTGCTGGGCCACT TCGGCGTCAACGAGAGTACGGGGCTGAGCCTGGAACAGGTCAAGAAGCTTAAGGAGAGATGGGGCTCCAACGAGTTACCGGCTGAAGAAG GAAAAACCTTGCTGGAACTTGTGATTGAGCAGTTTGAAGACTTGCTAGTTAGGATTTTATTACTGGCAGCATGTATATCTTTTGTTTTGG CTTGGTTTGAAGAAGGTGAAGAAACAATTACAGCCTTTGTAGAACCTTTTGTAATTTTACTCATATTAGTAGCCAATGCAATTGTGGGTG TATGGCAGGAAAGAAATGCTGAAAATGCCATCGAAGCCCTTAAGGAATATGAGCCTGAAATGGGCAAAGTGTATCGACAGGACAGAAAGA GTGTGCAGCGGATTAAAGCTAAAGACATAGTTCCTGGTGATATTGTAGAAATTGCTGTTGGTGACAAAGTTCCTGCTGATATAAGGTTAA CTTCCATCAAATCTACCACACTAAGAGTTGACCAGTCAATTCTCACAGGTGAATCTGTCTCTGTCATCAAGCACACTGATCCCGTCCCTG ACCCACGAGCTGTCAACCAAGATAAAAAGAACATGCTGTTTTCTGGTACAAACATTGCTGCTGGGAAAGCTATGGGAGTGGTGGTAGCAA CTGGAGTTAACACCGAAATTGGCAAGATCCGGGATGAAATGGTGGCAACAGAACAGGAGAGAACACCCCTTCAGCAAAAACTAGATGAAT TTGGGGAACAGCTTTCCAAAGTCATCTCCCTTATTTGCATTGCAGTCTGGATCATAAATATTGGGCACTTCAATGACCCGGTTCATGGAG GGTCCTGGATCAGAGGTGCTATTTACTACTTTAAAATTGCAGTGGCCCTGGCTGTAGCAGCCATTCCTGAAGGTCTGCCTGCAGTCATCA CCACCTGCCTGGCTCTTGGAACTCGCAGAATGGCAAAGAAAAATGCCATTGTTCGAAGCCTCCCGTCTGTGGAAACCCTTGGTTGTACTT CTGTTATCTGCTCAGACAAGACTGGTACACTTACAACAAACCAGATGTCAGTCTGCAGGATGTTCATTCTGGACAGAGTGGAAGGTGATA CTTGTTCCCTTAATGAGTTTACCATAACTGGATCAACTTATGCACCTATTGGAGAAGTGCATAAAGATGATAAACCAGTGAATTGTCACC AGTATGATGGTCTGGTAGAATTAGCAACAATTTGTGCTCTTTGTAATGACTCTGCTTTGGATTACAATGAGGCAAAGGGTGTGTATGAAA AAGTTGGAGAAGCTACAGAGACTGCTCTCACTTGCCTAGTAGAGAAGATGAATGTATTTGATACCGAATTGAAGGGTCTTTCTAAAATAG AACGTGCAAATGCCTGCAACTCAGGTGAGCCTGGCAAAGCTGGTGAGAAGGGACTGCCTGGTGCTCCTGGTCTGAGGGGTCTTCCTGGCA AAGATGGTGAGACAGGTGCTGCAGGACCCCCTGGCCCTGCTGGACCTGCTGGTGAACGAGGCGAGCAGGGTGCTCCTGGGCCATCTGGGT TCCAGGGACTTCCTGGCCCTCCTGGTCCCCCAGGTGAAGGTGGAAAACCAGGTGACCAGGGTGTTCCCGGTGAAGCTGGAGCCCCTGGCC TCGTGGGTCCCAGGGGTGAACGAGGTTTCCCAGGTGAACGTGGCTCTCCCGGTGCCCAGGGCCTCCAGGGTCCCCGTGGCCTCCCCGGCA CTCCTGGCACTGATGGTCCCAAAGGTGCATCTGGCCCAGCAGGCCCCCCTGGGGCTCAGGGCCCTCCAGGTCTTCAGGGAATGCCTGGCG AGAGGGGAGCAGCTGGTATCGCTGGGCCCAAAGGCGACAGGGGTGACGTTGGTGAGAAAGGCCCTGAGGGAGCCCCTGGAAAGGATGGTG GACGAGGCCTGACAGGTCCCATTGGCCCCCCTGGCCCAGCTGGTGCTAATGGCGAGAAGGGAGAAGTTGGACCTCCTGGTCCTGCAGGAA GTGCTGGTGCTCGTGGCGCTCCGGGTGAACGTGGAGAGACTGGGCCCCCCGGACCAGCGGGATTTGCTGGGCCTCCTGGTGCTGATGGCC AGCCTGGGGCCAAGGGTGAGCAAGGAGAGGCCGGCCAGAAAGGCGATGCTGGTGCCCCTGGTCCTCAGGGCCCCTCTGGAGCACCTGGGC CTCAGGGTCCTACTGGAGTGACTGGTCCTAAAGGAGCCCGAGGTGCCCAAGGCCCCCCGGGAGCCACTGGATTCCCTGGAGCTGCTGGCC GCGTTGGACCCCCAGGCTCCAATGGCAACCCTGGACCCCCTGGTCCCCCTGGTCCTTCTGGAAAAGATGGTCCCAAAGGTGCTCGAGGAG ACAGCGGCCCCCCTGGCCGAGCTGGTGAACCCGGCCTCCAAGGTCCTGCTGGACCCCCTGGCGAGAAGGGAGAGCCTGGAGATGACGGTC CCTCTGGTGCCGAAGGTCCACCAGGTCCCCAGGGTCTGGCTGGTCAGAGAGGCATCGTCGGTCTGCCTGGGCAACGTGGTGAGAGAGGAT TCCCTGGCTTGCCTGGCCCGTCGGGTGAGCCCGGCAAGCAGGGTGCTCCTGGAGCATCTGGAGACAGAGGTCCTCCTGGCCCCGTGGGTC CTCCTGGCCTGACGGGTCCTGCAGGTGAACCTGGACGAGAGGGAAGCCCCGGTGCTGATGGCCCCCCTGGCAGAGATGGCGCTGCTGGAG TCAAGGGTGATCGTGGTGAGACTGGTGCTGTGGGAGCTCCTGGAGCCCCTGGGCCCCCTGGCTCCCCTGGCCCCGCTGGTCCAACTGGCA AGCAAGGAGACAGAGGAGAAGCTGGTGCACAAGGCCCCATGGGACCCTCAGGACCAGCTGGAGCCCGGGGAATCCAGGGTCCTCAAGGCC CCAGAGGTGACAAAGGAGAGGCTGGAGAGCCTGGCGAGAGAGGCCTGAAGGGACACCGTGGCTTCACTGGTCTGCAGGGTCTGCCCGGCC CTCCTGGTCCTTCTGGAGACCAAGGTGCTTCTGGTCCTGCTGGTCCTTCTGGCCCTAGAGGTCCTCCTGGCCCCGTCGGTCCCTCTGGCA AAGATGGTGCTAATGGAATCCCTGGCCCCATTGGGCCTCCTGGTCCCCGTGGACGATCAGGCGAAACCGGCCCTGCTGGTCCTCCTGGAA ATCCTGGACCCCCTGGTCCTCCAGGTCCCCCTGGCCCTGGCATCGACATGTCCGCCTTTGCTGGCTTAGGCCCGAGAGAGAAGGGCCCCG ACCCCCTGCAGTACATGCGGGCCGACCAGGCAGCCGGTGGCCTGAGACAGCATGACGCCGAGGTGGATGCCACACTCAAGTCCCTCAACA ACCAGATTGAGAGCATCCGCAGCCCCGAGGGCTCCCGCAAGAACCCTGCTCGCACCTGCAGAGACCTGAAACTCTGCCACCCTGAGTGGA AGAGTGGAGACTACTGGATTGACCCCAACCAAGGCTGCACCTTGGACGCCATGAAGGTTTTCTGCAACATGGAGACTGGCGAGACTTGCG TCTACCCCAATCCAGCAAACGTTCCCAAGAAGAACTGGTGGAGCAGCAAGAGCAAGGAGAAGAAACACATCTGGTTTGGAGAAACCATCA ATGGTGGCTTCCATTTCAGCTATGGAGATGACAATCTGGCTCCCAACACTGCCAACGTCCAGATGACCTTCCTACGCCTGCTGTCCACGG AAGGCTCCCAGAACATCACCTACCACTGCAAGAACAGCATTGCCTATCTGGACGAAGCAGCTGGCAACCTCAAGAAGGCCCTGCTCATCC AGGGCTCCAATGACGTGGAGATCCGGGCAGAGGGCAATAGCAGGTTCACGTACACTGCCCTGAAGGATGGCTGCACGAAACATACCGGTA AGTGGGGCAAGACTGTTATCGAGTACCGGTCACAGAAGACCTCACGCCTCCCCATCATTGACATTGCACCCATGGACATAGGAGGGCCCG AGCAGGAATTCGGTGTGGACATAGGGCCGGTCTGCTTCTTGTAAAAACCTGAACCCAGAAACAACACAATCCGTTGCAAACCCAAAGGAC CCAAGTACTTTCCAATCTCAGTCACTCTAGGACTCTGCACTGAATGGCTGACCTGACCTGATGTCCATTCATCCCACCCTCTCACAGTTC GGACTTTTCTCCCCTCTCTTTCTAAGAGACCTGAACTGGGCAGACTGCAAAATAAAATCTCGGTGTTCTATTTATTTATTGTCTTCCTGT AAGACCTTCGGGTCAAGGCAGAGGCAGGAAACTAACTGGTGTGAGTCAAATGCCCCCTGAGTGACTGCCCCCAGCCCAGGCCAGAAGACC TCCCTTCAGGTGCCGGGCGCAGGAACTGTGTGTGTCCTACACAATGGTGCTATTCTGTGTCAAACACCTCTGTATTTTTTAAAACATCAA >7832_7832_1_ATP2A2-COL2A1_ATP2A2_chr12_110771948_ENST00000308664_COL2A1_chr12_48378382_ENST00000380518_length(amino acids)=1464AA_BP=924 MIASRERGGGSGAAACPPGGRLRAREALPSGEGREGGSGAPNPPCGARGRARGGCLGEGARGDSAPGEAEAAARGGGESPSAPGLPGWHE PAAGVRGGGEEAAGTGGEAGRAPEAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRIL LLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAV GDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQE RTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRS LPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSAL DYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGER GEQGAPGPSGFQGLPGPPGPPGEGGKPGDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQGLQGPRGLPGTPGTDGPKGASGPAGPPGAQ GPPGLQGMPGERGAAGIAGPKGDRGDVGEKGPEGAPGKDGGRGLTGPIGPPGPAGANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPA GFAGPPGADGQPGAKGEQGEAGQKGDAGAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPGATGFPGAAGRVGPPGSNGNPGPPGPPGPS GKDGPKGARGDSGPPGRAGEPGLQGPAGPPGEKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGPSGEPGKQGAPGAS GDRGPPGPVGPPGLTGPAGEPGREGSPGADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPGSPGPAGPTGKQGDRGEAGAQGPMGPSGPA GARGIQGPQGPRGDKGEAGEPGERGLKGHRGFTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRS GETGPAGPPGNPGPPGPPGPPGPGIDMSAFAGLGPREKGPDPLQYMRADQAAGGLRQHDAEVDATLKSLNNQIESIRSPEGSRKNPARTC RDLKLCHPEWKSGDYWIDPNQGCTLDAMKVFCNMETGETCVYPNPANVPKKNWWSSKSKEKKHIWFGETINGGFHFSYGDDNLAPNTANV QMTFLRLLSTEGSQNITYHCKNSIAYLDEAAGNLKKALLIQGSNDVEIRAEGNSRFTYTALKDGCTKHTGKWGKTVIEYRSQKTSRLPII -------------------------------------------------------------- >7832_7832_2_ATP2A2-COL2A1_ATP2A2_chr12_110771948_ENST00000395494_COL2A1_chr12_48378382_ENST00000380518_length(transcript)=4974nt_BP=1901nt GGCAGCGGCCGATAAATGCTATTAGAGCAGCCGCCGCGGAGCCGTCCCCGACGCCACCTCCTTTTCCTTCGCCGCAGTTTCCTCCGCCGC TGTCGGGCGTGCGGCGCTGAGGGACCCGGGCGAGCGCGCCGCGCACCGCCCCGCCGGCTCGCCTCCCTCGCCGCGTTCCGCCCTCAGTGG TCTGCCGGGCGCCCCCTCCTCCGGCCCGGGCGGGGCCTCTGATCGCCTCAAGAGAGCGGGGAGGGGGCTCGGGGGCCGCGGCCTGCCCTC CCGGCGGGCGGCTGAGGGCGAGGGAGGCCCTCCCTTCTGGCGAGGGGAGGGAGGGTGGGTCAGGAGCCCCCAACCCGCCCTGCGGAGCTC GGGGCCGCGCGAGGGGCGGTTGTCTGGGGGAGGGGGCGCGGGGTGATTCAGCGCCCGGCGAGGCGGAAGCGGCCGCAAGAGGAGGAGGGG AGAGCCCGTCCGCGCCTGGGCTCCCGGGGTGGCACGAGCCCGCGGCCGGAGTGCGAGGCGGAGGCGAGGAGGCCGCGGGGACGGGAGGCG AGGCCGGCCGGGCCCCCGAAGCCATGGAGAACGCGCACACCAAGACGGTGGAGGAGGTGCTGGGCCACTTCGGCGTCAACGAGAGTACGG GGCTGAGCCTGGAACAGGTCAAGAAGCTTAAGGAGAGATGGGGCTCCAACGAGTTACCGGCTGAAGAAGGAAAAACCTTGCTGGAACTTG TGATTGAGCAGTTTGAAGACTTGCTAGTTAGGATTTTATTACTGGCAGCATGTATATCTTTTGTTTTGGCTTGGTTTGAAGAAGGTGAAG AAACAATTACAGCCTTTGTAGAACCTTTTGTAATTTTACTCATATTAGTAGCCAATGCAATTGTGGGTGTATGGCAGGAAAGAAATGCTG AAAATGCCATCGAAGCCCTTAAGGAATATGAGCCTGAAATGGGCAAAGTGTATCGACAGGACAGAAAGAGTGTGCAGCGGATTAAAGCTA AAGACATAGTTCCTGGTGATATTGTAGAAATTGCTGGTGAATCTGTCTCTGTCATCAAGCACACTGATCCCGTCCCTGACCCACGAGCTG TCAACCAAGATAAAAAGAACATGCTGTTTTCTGGTACAAACATTGCTGCTGGGAAAGCTATGGGAGTGGTGGTAGCAACTGGAGTTAACA CCGAAATTGGCAAGATCCGGGATGAAATGGTGGCAACAGAACAGGAGAGAACACCCCTTCAGCAAAAACTAGATGAATTTGGGGAACAGC TTTCCAAAGTCATCTCCCTTATTTGCATTGCAGTCTGGATCATAAATATTGGGCACTTCAATGACCCGGTTCATGGAGGGTCCTGGATCA GAGGTGCTATTTACTACTTTAAAATTGCAGTGGCCCTGGCTGTAGCAGCCATTCCTGAAGGTCTGCCTGCAGTCATCACCACCTGCCTGG CTCTTGGAACTCGCAGAATGGCAAAGAAAAATGCCATTGTTCGAAGCCTCCCGTCTGTGGAAACCCTTGGTTGTACTTCTGTTATCTGCT CAGACAAGACTGGTACACTTACAACAAACCAGATGTCAGTCTGCAGGATGTTCATTCTGGACAGAGTGGAAGGTGATACTTGTTCCCTTA ATGAGTTTACCATAACTGGATCAACTTATGCACCTATTGGAGAAGTGCATAAAGATGATAAACCAGTGAATTGTCACCAGTATGATGGTC TGGTAGAATTAGCAACAATTTGTGCTCTTTGTAATGACTCTGCTTTGGATTACAATGAGGCAAAGGGTGTGTATGAAAAAGTTGGAGAAG CTACAGAGACTGCTCTCACTTGCCTAGTAGAGAAGATGAATGTATTTGATACCGAATTGAAGGGTCTTTCTAAAATAGAACGTGCAAATG CCTGCAACTCAGGTGAGCCTGGCAAAGCTGGTGAGAAGGGACTGCCTGGTGCTCCTGGTCTGAGGGGTCTTCCTGGCAAAGATGGTGAGA CAGGTGCTGCAGGACCCCCTGGCCCTGCTGGACCTGCTGGTGAACGAGGCGAGCAGGGTGCTCCTGGGCCATCTGGGTTCCAGGGACTTC CTGGCCCTCCTGGTCCCCCAGGTGAAGGTGGAAAACCAGGTGACCAGGGTGTTCCCGGTGAAGCTGGAGCCCCTGGCCTCGTGGGTCCCA GGGGTGAACGAGGTTTCCCAGGTGAACGTGGCTCTCCCGGTGCCCAGGGCCTCCAGGGTCCCCGTGGCCTCCCCGGCACTCCTGGCACTG ATGGTCCCAAAGGTGCATCTGGCCCAGCAGGCCCCCCTGGGGCTCAGGGCCCTCCAGGTCTTCAGGGAATGCCTGGCGAGAGGGGAGCAG CTGGTATCGCTGGGCCCAAAGGCGACAGGGGTGACGTTGGTGAGAAAGGCCCTGAGGGAGCCCCTGGAAAGGATGGTGGACGAGGCCTGA CAGGTCCCATTGGCCCCCCTGGCCCAGCTGGTGCTAATGGCGAGAAGGGAGAAGTTGGACCTCCTGGTCCTGCAGGAAGTGCTGGTGCTC GTGGCGCTCCGGGTGAACGTGGAGAGACTGGGCCCCCCGGACCAGCGGGATTTGCTGGGCCTCCTGGTGCTGATGGCCAGCCTGGGGCCA AGGGTGAGCAAGGAGAGGCCGGCCAGAAAGGCGATGCTGGTGCCCCTGGTCCTCAGGGCCCCTCTGGAGCACCTGGGCCTCAGGGTCCTA CTGGAGTGACTGGTCCTAAAGGAGCCCGAGGTGCCCAAGGCCCCCCGGGAGCCACTGGATTCCCTGGAGCTGCTGGCCGCGTTGGACCCC CAGGCTCCAATGGCAACCCTGGACCCCCTGGTCCCCCTGGTCCTTCTGGAAAAGATGGTCCCAAAGGTGCTCGAGGAGACAGCGGCCCCC CTGGCCGAGCTGGTGAACCCGGCCTCCAAGGTCCTGCTGGACCCCCTGGCGAGAAGGGAGAGCCTGGAGATGACGGTCCCTCTGGTGCCG AAGGTCCACCAGGTCCCCAGGGTCTGGCTGGTCAGAGAGGCATCGTCGGTCTGCCTGGGCAACGTGGTGAGAGAGGATTCCCTGGCTTGC CTGGCCCGTCGGGTGAGCCCGGCAAGCAGGGTGCTCCTGGAGCATCTGGAGACAGAGGTCCTCCTGGCCCCGTGGGTCCTCCTGGCCTGA CGGGTCCTGCAGGTGAACCTGGACGAGAGGGAAGCCCCGGTGCTGATGGCCCCCCTGGCAGAGATGGCGCTGCTGGAGTCAAGGGTGATC GTGGTGAGACTGGTGCTGTGGGAGCTCCTGGAGCCCCTGGGCCCCCTGGCTCCCCTGGCCCCGCTGGTCCAACTGGCAAGCAAGGAGACA GAGGAGAAGCTGGTGCACAAGGCCCCATGGGACCCTCAGGACCAGCTGGAGCCCGGGGAATCCAGGGTCCTCAAGGCCCCAGAGGTGACA AAGGAGAGGCTGGAGAGCCTGGCGAGAGAGGCCTGAAGGGACACCGTGGCTTCACTGGTCTGCAGGGTCTGCCCGGCCCTCCTGGTCCTT CTGGAGACCAAGGTGCTTCTGGTCCTGCTGGTCCTTCTGGCCCTAGAGGTCCTCCTGGCCCCGTCGGTCCCTCTGGCAAAGATGGTGCTA ATGGAATCCCTGGCCCCATTGGGCCTCCTGGTCCCCGTGGACGATCAGGCGAAACCGGCCCTGCTGGTCCTCCTGGAAATCCTGGACCCC CTGGTCCTCCAGGTCCCCCTGGCCCTGGCATCGACATGTCCGCCTTTGCTGGCTTAGGCCCGAGAGAGAAGGGCCCCGACCCCCTGCAGT ACATGCGGGCCGACCAGGCAGCCGGTGGCCTGAGACAGCATGACGCCGAGGTGGATGCCACACTCAAGTCCCTCAACAACCAGATTGAGA GCATCCGCAGCCCCGAGGGCTCCCGCAAGAACCCTGCTCGCACCTGCAGAGACCTGAAACTCTGCCACCCTGAGTGGAAGAGTGGAGACT ACTGGATTGACCCCAACCAAGGCTGCACCTTGGACGCCATGAAGGTTTTCTGCAACATGGAGACTGGCGAGACTTGCGTCTACCCCAATC CAGCAAACGTTCCCAAGAAGAACTGGTGGAGCAGCAAGAGCAAGGAGAAGAAACACATCTGGTTTGGAGAAACCATCAATGGTGGCTTCC ATTTCAGCTATGGAGATGACAATCTGGCTCCCAACACTGCCAACGTCCAGATGACCTTCCTACGCCTGCTGTCCACGGAAGGCTCCCAGA ACATCACCTACCACTGCAAGAACAGCATTGCCTATCTGGACGAAGCAGCTGGCAACCTCAAGAAGGCCCTGCTCATCCAGGGCTCCAATG ACGTGGAGATCCGGGCAGAGGGCAATAGCAGGTTCACGTACACTGCCCTGAAGGATGGCTGCACGAAACATACCGGTAAGTGGGGCAAGA CTGTTATCGAGTACCGGTCACAGAAGACCTCACGCCTCCCCATCATTGACATTGCACCCATGGACATAGGAGGGCCCGAGCAGGAATTCG GTGTGGACATAGGGCCGGTCTGCTTCTTGTAAAAACCTGAACCCAGAAACAACACAATCCGTTGCAAACCCAAAGGACCCAAGTACTTTC CAATCTCAGTCACTCTAGGACTCTGCACTGAATGGCTGACCTGACCTGATGTCCATTCATCCCACCCTCTCACAGTTCGGACTTTTCTCC CCTCTCTTTCTAAGAGACCTGAACTGGGCAGACTGCAAAATAAAATCTCGGTGTTCTATTTATTTATTGTCTTCCTGTAAGACCTTCGGG TCAAGGCAGAGGCAGGAAACTAACTGGTGTGAGTCAAATGCCCCCTGAGTGACTGCCCCCAGCCCAGGCCAGAAGACCTCCCTTCAGGTG CCGGGCGCAGGAACTGTGTGTGTCCTACACAATGGTGCTATTCTGTGTCAAACACCTCTGTATTTTTTAAAACATCAATTGATATTAAAA >7832_7832_2_ATP2A2-COL2A1_ATP2A2_chr12_110771948_ENST00000395494_COL2A1_chr12_48378382_ENST00000380518_length(amino acids)=1437AA_BP=897 MIASRERGGGSGAAACPPGGRLRAREALPSGEGREGGSGAPNPPCGARGRARGGCLGEGARGDSAPGEAEAAARGGGESPSAPGLPGWHE PAAGVRGGGEEAAGTGGEAGRAPEAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRIL LLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAG ESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVW IINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMS VCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKM NVFDTELKGLSKIERANACNSGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGERGEQGAPGPSGFQGLPGPPGPPGEGGKP GDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQGLQGPRGLPGTPGTDGPKGASGPAGPPGAQGPPGLQGMPGERGAAGIAGPKGDRGDV GEKGPEGAPGKDGGRGLTGPIGPPGPAGANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPAGFAGPPGADGQPGAKGEQGEAGQKGDA GAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPGATGFPGAAGRVGPPGSNGNPGPPGPPGPSGKDGPKGARGDSGPPGRAGEPGLQGPA GPPGEKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGPSGEPGKQGAPGASGDRGPPGPVGPPGLTGPAGEPGREGSP GADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPGSPGPAGPTGKQGDRGEAGAQGPMGPSGPAGARGIQGPQGPRGDKGEAGEPGERGLK GHRGFTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRSGETGPAGPPGNPGPPGPPGPPGPGIDM SAFAGLGPREKGPDPLQYMRADQAAGGLRQHDAEVDATLKSLNNQIESIRSPEGSRKNPARTCRDLKLCHPEWKSGDYWIDPNQGCTLDA MKVFCNMETGETCVYPNPANVPKKNWWSSKSKEKKHIWFGETINGGFHFSYGDDNLAPNTANVQMTFLRLLSTEGSQNITYHCKNSIAYL -------------------------------------------------------------- >7832_7832_3_ATP2A2-COL2A1_ATP2A2_chr12_110771948_ENST00000539276_COL2A1_chr12_48378382_ENST00000380518_length(transcript)=4601nt_BP=1528nt CCCGTCCGCGCCTGGGCTCCCGGGGTGGCACGAGCCCGCGGCCGGAGTGCGAGGCGGAGGCGAGGAGGCCGCGGGGACGGGAGGCGAGGC CGGCCGGGCCCCCGAAGCCATGGAGAACGCGCACACCAAGACGGTGGAGGAGGTGCTGGGCCACTTCGGCGTCAACGAGAGTACGGGGCT GAGCCTGGAACAGGTCAAGAAGCTTAAGGAGAGATGGGGCTCCAACGAGTTACCGGCTGAAGAAGGAAAAACCTTGCTGGAACTTGTGAT TGAGCAGTTTGAAGACTTGCTAGTTAGGATTTTATTACTGGCAGCATGTATATCTTTTGTTTTGGCTTGGTTTGAAGAAGGTGAAGAAAC AATTACAGCCTTTGTAGAACCTTTTGTAATTTTACTCATATTAGTAGCCAATGCAATTGTGGGTGTATGGCAGGAAAGAAATGCTGAAAA TGCCATCGAAGCCCTTAAGGAATATGAGCCTGAAATGGGCAAAGTGTATCGACAGGACAGAAAGAGTGTGCAGCGGATTAAAGCTAAAGA CATAGTTCCTGGTGATATTGTAGAAATTGCTGTTGGTGACAAAGTTCCTGCTGATATAAGGTTAACTTCCATCAAATCTACCACACTAAG AGTTGACCAGTCAATTCTCACAGGTGAATCTGTCTCTGTCATCAAGCACACTGATCCCGTCCCTGACCCACGAGCTGTCAACCAAGATAA AAAGAACATGCTGTTTTCTGGTACAAACATTGCTGCTGGGAAAGCTATGGGAGTGGTGGTAGCAACTGGAGTTAACACCGAAATTGGCAA GATCCGGGATGAAATGGTGGCAACAGAACAGGAGAGAACACCCCTTCAGCAAAAACTAGATGAATTTGGGGAACAGCTTTCCAAAGTCAT CTCCCTTATTTGCATTGCAGTCTGGATCATAAATATTGGGCACTTCAATGACCCGGTTCATGGAGGGTCCTGGATCAGAGGTGCTATTTA CTACTTTAAAATTGCAGTGGCCCTGGCTGTAGCAGCCATTCCTGAAGGTCTGCCTGCAGTCATCACCACCTGCCTGGCTCTTGGAACTCG CAGAATGGCAAAGAAAAATGCCATTGTTCGAAGCCTCCCGTCTGTGGAAACCCTTGGTTGTACTTCTGTTATCTGCTCAGACAAGACTGG TACACTTACAACAAACCAGATGTCAGTCTGCAGGATGTTCATTCTGGACAGAGTGGAAGGTGATACTTGTTCCCTTAATGAGTTTACCAT AACTGGATCAACTTATGCACCTATTGGAGAAGTGCATAAAGATGATAAACCAGTGAATTGTCACCAGTATGATGGTCTGGTAGAATTAGC AACAATTTGTGCTCTTTGTAATGACTCTGCTTTGGATTACAATGAGGCAAAGGGTGTGTATGAAAAAGTTGGAGAAGCTACAGAGACTGC TCTCACTTGCCTAGTAGAGAAGATGAATGTATTTGATACCGAATTGAAGGGTCTTTCTAAAATAGAACGTGCAAATGCCTGCAACTCAGG TGAGCCTGGCAAAGCTGGTGAGAAGGGACTGCCTGGTGCTCCTGGTCTGAGGGGTCTTCCTGGCAAAGATGGTGAGACAGGTGCTGCAGG ACCCCCTGGCCCTGCTGGACCTGCTGGTGAACGAGGCGAGCAGGGTGCTCCTGGGCCATCTGGGTTCCAGGGACTTCCTGGCCCTCCTGG TCCCCCAGGTGAAGGTGGAAAACCAGGTGACCAGGGTGTTCCCGGTGAAGCTGGAGCCCCTGGCCTCGTGGGTCCCAGGGGTGAACGAGG TTTCCCAGGTGAACGTGGCTCTCCCGGTGCCCAGGGCCTCCAGGGTCCCCGTGGCCTCCCCGGCACTCCTGGCACTGATGGTCCCAAAGG TGCATCTGGCCCAGCAGGCCCCCCTGGGGCTCAGGGCCCTCCAGGTCTTCAGGGAATGCCTGGCGAGAGGGGAGCAGCTGGTATCGCTGG GCCCAAAGGCGACAGGGGTGACGTTGGTGAGAAAGGCCCTGAGGGAGCCCCTGGAAAGGATGGTGGACGAGGCCTGACAGGTCCCATTGG CCCCCCTGGCCCAGCTGGTGCTAATGGCGAGAAGGGAGAAGTTGGACCTCCTGGTCCTGCAGGAAGTGCTGGTGCTCGTGGCGCTCCGGG TGAACGTGGAGAGACTGGGCCCCCCGGACCAGCGGGATTTGCTGGGCCTCCTGGTGCTGATGGCCAGCCTGGGGCCAAGGGTGAGCAAGG AGAGGCCGGCCAGAAAGGCGATGCTGGTGCCCCTGGTCCTCAGGGCCCCTCTGGAGCACCTGGGCCTCAGGGTCCTACTGGAGTGACTGG TCCTAAAGGAGCCCGAGGTGCCCAAGGCCCCCCGGGAGCCACTGGATTCCCTGGAGCTGCTGGCCGCGTTGGACCCCCAGGCTCCAATGG CAACCCTGGACCCCCTGGTCCCCCTGGTCCTTCTGGAAAAGATGGTCCCAAAGGTGCTCGAGGAGACAGCGGCCCCCCTGGCCGAGCTGG TGAACCCGGCCTCCAAGGTCCTGCTGGACCCCCTGGCGAGAAGGGAGAGCCTGGAGATGACGGTCCCTCTGGTGCCGAAGGTCCACCAGG TCCCCAGGGTCTGGCTGGTCAGAGAGGCATCGTCGGTCTGCCTGGGCAACGTGGTGAGAGAGGATTCCCTGGCTTGCCTGGCCCGTCGGG TGAGCCCGGCAAGCAGGGTGCTCCTGGAGCATCTGGAGACAGAGGTCCTCCTGGCCCCGTGGGTCCTCCTGGCCTGACGGGTCCTGCAGG TGAACCTGGACGAGAGGGAAGCCCCGGTGCTGATGGCCCCCCTGGCAGAGATGGCGCTGCTGGAGTCAAGGGTGATCGTGGTGAGACTGG TGCTGTGGGAGCTCCTGGAGCCCCTGGGCCCCCTGGCTCCCCTGGCCCCGCTGGTCCAACTGGCAAGCAAGGAGACAGAGGAGAAGCTGG TGCACAAGGCCCCATGGGACCCTCAGGACCAGCTGGAGCCCGGGGAATCCAGGGTCCTCAAGGCCCCAGAGGTGACAAAGGAGAGGCTGG AGAGCCTGGCGAGAGAGGCCTGAAGGGACACCGTGGCTTCACTGGTCTGCAGGGTCTGCCCGGCCCTCCTGGTCCTTCTGGAGACCAAGG TGCTTCTGGTCCTGCTGGTCCTTCTGGCCCTAGAGGTCCTCCTGGCCCCGTCGGTCCCTCTGGCAAAGATGGTGCTAATGGAATCCCTGG CCCCATTGGGCCTCCTGGTCCCCGTGGACGATCAGGCGAAACCGGCCCTGCTGGTCCTCCTGGAAATCCTGGACCCCCTGGTCCTCCAGG TCCCCCTGGCCCTGGCATCGACATGTCCGCCTTTGCTGGCTTAGGCCCGAGAGAGAAGGGCCCCGACCCCCTGCAGTACATGCGGGCCGA CCAGGCAGCCGGTGGCCTGAGACAGCATGACGCCGAGGTGGATGCCACACTCAAGTCCCTCAACAACCAGATTGAGAGCATCCGCAGCCC CGAGGGCTCCCGCAAGAACCCTGCTCGCACCTGCAGAGACCTGAAACTCTGCCACCCTGAGTGGAAGAGTGGAGACTACTGGATTGACCC CAACCAAGGCTGCACCTTGGACGCCATGAAGGTTTTCTGCAACATGGAGACTGGCGAGACTTGCGTCTACCCCAATCCAGCAAACGTTCC CAAGAAGAACTGGTGGAGCAGCAAGAGCAAGGAGAAGAAACACATCTGGTTTGGAGAAACCATCAATGGTGGCTTCCATTTCAGCTATGG AGATGACAATCTGGCTCCCAACACTGCCAACGTCCAGATGACCTTCCTACGCCTGCTGTCCACGGAAGGCTCCCAGAACATCACCTACCA CTGCAAGAACAGCATTGCCTATCTGGACGAAGCAGCTGGCAACCTCAAGAAGGCCCTGCTCATCCAGGGCTCCAATGACGTGGAGATCCG GGCAGAGGGCAATAGCAGGTTCACGTACACTGCCCTGAAGGATGGCTGCACGAAACATACCGGTAAGTGGGGCAAGACTGTTATCGAGTA CCGGTCACAGAAGACCTCACGCCTCCCCATCATTGACATTGCACCCATGGACATAGGAGGGCCCGAGCAGGAATTCGGTGTGGACATAGG GCCGGTCTGCTTCTTGTAAAAACCTGAACCCAGAAACAACACAATCCGTTGCAAACCCAAAGGACCCAAGTACTTTCCAATCTCAGTCAC TCTAGGACTCTGCACTGAATGGCTGACCTGACCTGATGTCCATTCATCCCACCCTCTCACAGTTCGGACTTTTCTCCCCTCTCTTTCTAA GAGACCTGAACTGGGCAGACTGCAAAATAAAATCTCGGTGTTCTATTTATTTATTGTCTTCCTGTAAGACCTTCGGGTCAAGGCAGAGGC AGGAAACTAACTGGTGTGAGTCAAATGCCCCCTGAGTGACTGCCCCCAGCCCAGGCCAGAAGACCTCCCTTCAGGTGCCGGGCGCAGGAA CTGTGTGTGTCCTACACAATGGTGCTATTCTGTGTCAAACACCTCTGTATTTTTTAAAACATCAATTGATATTAAAAATGAAAAGATTAT >7832_7832_3_ATP2A2-COL2A1_ATP2A2_chr12_110771948_ENST00000539276_COL2A1_chr12_48378382_ENST00000380518_length(amino acids)=1349AA_BP=809 MENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVE PFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSIL TGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIA VWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQ MSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVE KMNVFDTELKGLSKIERANACNSGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGERGEQGAPGPSGFQGLPGPPGPPGEGG KPGDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQGLQGPRGLPGTPGTDGPKGASGPAGPPGAQGPPGLQGMPGERGAAGIAGPKGDRG DVGEKGPEGAPGKDGGRGLTGPIGPPGPAGANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPAGFAGPPGADGQPGAKGEQGEAGQKG DAGAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPGATGFPGAAGRVGPPGSNGNPGPPGPPGPSGKDGPKGARGDSGPPGRAGEPGLQG PAGPPGEKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGPSGEPGKQGAPGASGDRGPPGPVGPPGLTGPAGEPGREG SPGADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPGSPGPAGPTGKQGDRGEAGAQGPMGPSGPAGARGIQGPQGPRGDKGEAGEPGERG LKGHRGFTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRSGETGPAGPPGNPGPPGPPGPPGPGI DMSAFAGLGPREKGPDPLQYMRADQAAGGLRQHDAEVDATLKSLNNQIESIRSPEGSRKNPARTCRDLKLCHPEWKSGDYWIDPNQGCTL DAMKVFCNMETGETCVYPNPANVPKKNWWSSKSKEKKHIWFGETINGGFHFSYGDDNLAPNTANVQMTFLRLLSTEGSQNITYHCKNSIA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ATP2A2-COL2A1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 575_594 | 473.0 | 998.0 | HAX1 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 575_594 | 446.0 | 1016.0 | HAX1 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 575_594 | 473.0 | 1043.0 | HAX1 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 787_807 | 473.0 | 998.0 | PLN |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 931_942 | 473.0 | 998.0 | PLN |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 787_807 | 446.0 | 1016.0 | PLN |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 931_942 | 446.0 | 1016.0 | PLN |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 787_807 | 473.0 | 1043.0 | PLN |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 931_942 | 473.0 | 1043.0 | PLN |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000308664 | + | 11 | 21 | 788_1042 | 473.0 | 998.0 | TMEM64 and PDIA3 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000395494 | + | 10 | 19 | 788_1042 | 446.0 | 1016.0 | TMEM64 and PDIA3 |
Hgene | ATP2A2 | chr12:110771948 | chr12:48378382 | ENST00000539276 | + | 11 | 20 | 788_1042 | 473.0 | 1043.0 | TMEM64 and PDIA3 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ATP2A2-COL2A1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ATP2A2-COL2A1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |